Trials / Completed
CompletedNCT00169585
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
A National, Multicentric, Randomised, Controlled Trial. Applications of a Critical Pathway Using Levofloxacin for the Management of Patients With Abnormal PSA.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric, national, prospective, parallel group, controlled. The Subjects in every center will be randomized and assigned to the pharmacologic arm or the one with the biochemical monitoring
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levofloxacin oral tablets |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2005-09-15
- Last updated
- 2017-05-30
Locations
19 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00169585. Inclusion in this directory is not an endorsement.